TrialPLoS medicine2019

Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.

Zita-Rose Manjaly Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.